Altered Fibrin Clot Properties in Patients With Cerebral Venous Sinus Thrombosis: Association With the Risk of Recurrence
Authors:
Siudut J, Świat M, Undas A
Academic press:
Stroke (rok: 2015, tom: 46, strony: 2665-2668), Wydawca: American Heart Association
Determinants of the elevated factor VIII activity in patients following venous thromboembolism
Authors:
Lech M, Kościelniak B, Bryk AH, Undas A
Academic press:
Przegląd Lekarski (rok: 2016, tom: 73, strony: 210-215), Wydawca: Przegląd Lekarski
Faster fibrin clot degradation characterizes patients with central pulmonary embolism at a low risk of recurrent peripheral embolism
Authors:
Kupis RW, Goldman-Mazur S, Polak M, Ząbczyk M, Undas A
Academic press:
Sci Rep (rok: 2019, tom: 9, strony: 72), Wydawca: Nature
Iron deficiency: a novel risk factor of recurrence in patients after unprovoked venous thromboembolism
Authors:
Potaczek DP, Jankowska EA, Wypasek E, Undas A
Academic press:
Pol Arch Med Wewn (rok: 2016, tom: 126, strony: 159-165), Wydawca: Medycyna Praktyczna
Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis
Authors:
Goldman S, Frączek P, Szklanny K, Papuga-Szela E, Stanisz A, Undas A
Academic press:
Thromb Haemost (rok: 2018, tom: 118, strony: 654-663), Wydawca: Thieme
Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study
Authors:
Cieslik J, Mrozinska S, Broniatowska E, Undas A
Academic press:
Blood (rok: 2018, tom: 131, strony: 797-807), Wydawca: American Society of Hematology
Antithrombin Rouen IV mutation in Polish patient with deep vein thrombosis
Authors:
Brutkowski K, Wypasek E, Corral J, Undas A
Academic press:
Acta Haematologica Polonica (rok: 2015, tom: 46, strony: 393-395), Wydawca: Elsevier
Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism
Authors:
Bryk AH, Piróg M, Plens K, Undas A
Academic press:
Vascul Pharmacol (rok: 2016, tom: 87, strony: 242-247), Wydawca: Elsevier
How to assess fibrinogen levels and fibrin clot properties in clinical practice?
Academic press:
Semin Thromb Hemost (rok: 2016, tom: 42, strony: 381-388), Wydawca: Thieme
Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban
Authors:
Janion-Sadowska A, Natorska J, Siudut J, Zabczyk M, Stanisz A, Undas A
Academic press:
Thromb Haemost (rok: 2017, tom: 117, strony: 1739-1749), Wydawca: Schattauer
Prothrombotic fibrin clot phenotype is associated with recurrent pulmonary embolism after discontinuation of anticoagulant therapy
Authors:
Zabczyk M, Plens K, Wojtowicz W, Undas A
Academic press:
Arterioscler Thromb Vasc Biol (rok: 2017, tom: 37, strony: 365-373), Wydawca: American Heart Association
Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increasedrisk of postthrombotic syndrome
Authors:
Siudut J, Grela M, Wypasek E, Plens K, Undas A
Academic press:
J Thromb Haemost (rok: 2016, tom: 14, strony: 784-793), Wydawca: Wiley Online Library
Reduced plasma fibrin clot permeability is associated with recurrent thromboembolic events in patients with antiphospholipid syndrome
Authors:
Celinska-Lowenhoff M, Zabczyk M, Iwaniec T, Plens K, Musiał J, Undas A
Academic press:
Rheumatology (Oxford) (rok: 2018, tom: 57, strony: 1340-1349), Wydawca: Oxford University Press
Venous thromboembolism associated with protein S deficiency due to Arg451* mutation in PROS1 gene: a case report and a literature review
Authors:
Wypasek E, Karpinski M, Alhenc-Gelas M, Undas A
Academic press:
Journal of Genetics (rok: 2017, tom: 96, strony: 1047-1051), Wydawca: Springer
Determinants of Elevated Levels of Natural Anticoagulants in Healthy Subjects
Authors:
Kościelniak B, Wypasek E, Undas A
Academic press:
Adv Clin Exp Med (rok: 2015, tom: 24, strony: 791-800), Wydawca: Wroclaw Medical University
Protein N-linked homocysteine is associated with recurrence of venous thromboembolism
Authors:
Szlauer A, Mielimonka A, Głowacki R, Borowczyk K, Stachniuk J, Undas A
Academic press:
Thromb Res (rok: 2015, tom: 136, strony: 911-916), Wydawca: Elsevier
The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome
Authors:
Malec K, Góralczyk T, Undas A
Academic press:
Thromb Res (rok: 2016, tom: 152, strony: 93-97), Wydawca: Elsevier
Differences in plasma fibrin clot composition in patients with thrombotic antiphospholipid syndrome compared with venous thromboembolism
Authors:
Stachowicz A, Zabczyk M, Natorska J, Suski M, Olszanecki R, Korbut R, Wiśniewski JR, Undas A
Academic press:
Sci Rep (rok: 2018, tom: 8, strony: 17301), Wydawca: Nature
Prothrombotic fibrin clot phenotype in patients with deep vein thrombosis and pulmonary embolism: a new risk factor for recurrence
Academic press:
BioMed Research International (rok: 2017, tom: 2017, strony: 8196256), Wydawca: Hindawi
Prothrombotic state in patients with a left atrial appendage thrombus of unknown origin and cerebrovascular events
Authors:
Meus R, Son M, Sobczyk D, Undas A
Academic press:
Stroke (rok: 2016, tom: 47, strony: 1872-1878), Wydawca: American Heart Association
Recurrent venous thromboembolism patients form clots with lower elastic modulus than those formed by patients with non-recurrent disease
Authors:
Baker SR, Zabczyk M, Macrae FL, Duval C, Undas A, Ariëns RAS
Academic press:
J Thromb Haemost (rok: 2019, tom: 17, strony: 618-626), Wydawca: Wiley
Impaired plasminogen binding in patients with venous thromboembolism: association with protein carbonylation
Authors:
Siudut J, Natorska J, Ząbczyk M, Zając D, Seweryn K, Rąpała-Kozik M, Undas A
Academic press:
Thrombosis Res (rok: 2018, tom: 163, strony: 45644), Wydawca: Elsevier